Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Unfractionated Heparin (UFH) has been conventionally used during Coronary Angiography (CAG). However, no data is available
for the dosage required. Vascular complications are still frequent in special group of patients. The objective of this study was
to determine the incidence of bleeding, vascular, and ischemic complications using three different heparin regimens after successful
coronary angiography. This study enrolled 105 patients divided into three groups: Group 1: (n=35 patients) receiving a dose of 5000
IU (systemic heparinization), Group 2: (n=35 patients) receiving a dose of 5000 IU of heparin on the flush saline and Group 3: (n=35
patients) control group will receive flush saline, i.e., normal saline flush. All patients included in the study will be subjected to full
history taking, complete general and local examination of the heart and blood vessels, 12 leads resting ECG, Routine laboratory
investigations including fasting blood sugar, liver and kidney function tests, complete blood picture, lipid profile and coagulation
profile. Descriptive statistics was done including mean, standard deviation and percentage. Comparison between groups was done
using one way analysis of variance and comparison between the parametric variables was done using chi-square test. Results of the
current study showed that there was no significant difference between the three groups regarding the number of diseased vessels
or the incidence of slow coronary flow or incidence of normal coronary arteries (p>0.05). The clotting time and PTT were not
significantly different in the three groups before coronary angiography (p>0.05). After coronary angiography, clotting time and PTT
were significantly higher among group I and II than that of group III (p<0.05). Comparison between before and after coronary
angiography in group I and II, the results showed that the clotting time and PTT increased significantly after the procedure (p<0.05)
while, in group III there were no significant difference between before and after the procedure (p>0.05). The sheath removal duration
was significantly higher among group I and group II than that of group III (p<0.05). There were no major complications recorded in
any of the patients in the three groups. Routine elective coronary angiography may be performed without the use of UFH was found
to be safe. However, further detail study is recommended.